IRIC is delighted by the renewed funding from the Richard and Edith Strauss Foundation in support of cancer research
Published on June 5, 2020
IRIC would like to offer its heartfelt thanks for the commitment made by the Richard and Edith Strauss Foundation, which is renewing its support for 2 promising cancer research projects.
A $200,000 donation was made to the Pediatric Leukemia Project led by Brian Wilhelm, Principal Investigator at IRIC, and by Dr. Sonia Cellot, Pediatric hematologist at CHU Saint-Justine.
“The support provided to this project will enable us to use the latest single-cell sequencing technology to gain a better understanding of the genetic characteristics of rare cells that can cause high fatality pediatric leukemias. Furthermore, the project will enable us to develop improved technologies for isolating and manipulating these populations of rare cells” points out Brian Wilhelm.
A second research project led by Dr. Guy Sauvageau involving acute myeloid leukemia also received $100,000 in new funding from the Foundation.
“The project funded by the Richard and Edith Strauss Foundation is part of the work carried out by my laboratory to develop new therapies for treating acute myeloid leukemia. More specifically, it seeks to identify the mechanisms of resistance to certain drugs currently being developed at the clinical level for the treatment of acute myeloid leukemia. The contribution made by the Richard and Edith Strauss Foundation is vital to the successful completion of this project, thus providing the opportunity to consider new treatment options for patients suffering from acute myeloid leukemia” says Guy Sauvageau.
Our donors are part of the solution. Their unwavering support is invaluable in helping our investigators carry out their research work and move forward in the fight against cancer. Supporting research is more vital than ever to defeat this scourge that affects us all.